Jim Simons Roivant Sciences Ltd. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.17 - $12.5 $3.33 Million - $4.1 Million	327,700 New	327,700 $3.78 Million
Q1 2024 May 13, 2024	BUY	$9.87 - $11.8 $9.95 Million - $11.9 Million	1,008,600 New	1,008,600 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $72,981 - $692,604	143,100 Added 169.75%	227,400 $732,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $4.84 $236,883 - $408,012	84,300 New	84,300 $343,000
Q1 2022 May 13, 2022	SELL	$4.74 - $9.91 $157,368 - $329,012	-33,200 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.86 - $13.52 $194,552 - $448,864	33,200 New	33,200 $335,000

332

505M

573K

739K

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.43B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.